g-TUBE, the latest innovation from Covaris, is a single-use consumable that enables scientists to shear genomic DNA into selected fragments sizes ranging from 6kbp to 20kbp. View more >>

Covaris to Supply the BGI with High-Throughput DNA Shearing for Next-Generation Sequencing

Beijing, China and Woburn, Massachusetts, USA—July 11, 2011—Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System. View more >>

Covaris Introduces Bench-top, AFA-based Process Technology

Woburn, MA—March 25, 2011—Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System. View more >>

Caliper And Covaris Establish Co-Marketing Agreement To Simplify Next Generation Sequencing

HOPKINTON, Mass.—Feb. 23, 2011 /PRNewswire/—Caliper Life Sciences, Inc. (CALP: 6.64 -0.15 -2.21%) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris' acoustic DNA shearing platforms and Caliper's automation and microfluidics technologies to develop automated workflows for next generation sequencing experiments. View more >>

Covaris receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011.

WOBURN, MA—February 8, 2011—The Covaris® LE220™ high performance ultra-sonicator has received the prestigious SLAS New Product Award at the LabAutomation 2011 conference in Palm Springs CA. With over 4,400 attendees, LabAuto is the premier laboratory automation conference and exhibition, bringing science, technology, and industry together. View more >>

Tecan and Covaris co-market Freedom EVO® with Adaptive Focused Acoustics™

Männedorf, Switzerland—November 18, 2010—Tecan is collaborating with Covaris, Inc., a rapidly growing company providing advanced sample preparation solutions for life and analytical science, to co­promote the Freedom EVO® liquid handling platform with integrated Adaptive Focused Acoustics™ (AFA). View more >>

Covaris Signs Co-Marketing Agreement with Illumina to Combine Next-Gen sequencing platforms with Controlled DNA Shearing

WOBURN, MA—September 10, 2010—Covaris Inc. (a privately-held MA based company) today announced that it has signed a co-marketing agreement with Illumina, Inc. (NASDAQ:ILMN) making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer. View more >>

Agilent Technologies and Covaris Sign Co-Marketing Agreement Pairing Target Enrichment with DNA Shearing for Next-Gen Sequencing

SANTA CLARA, CA and WOBURN, MA—January 5, 2010—Agilent Technologies, Inc. (NYSE:A) and Covaris Inc. today announced a co-marketing agreement in which Covaris S2 DNA shearing technology will be marketed with the Agilent SureSelect Target Enrichment System to streamline next-generation sequencing experiments. View more >>